Plain-English translation of NCT01561157 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term study of people with porphyrias — a group of rare metabolic disorders caused by problems in how your body makes heme, a critical component of red blood cells. Researchers want to follow people with confirmed porphyria diagnoses over time to better understand how these diseases progress, what symptoms people experience, and how well current treatments work.
Porphyrias are very rare, and doctors often don't diagnose them quickly, which can delay treatment and cause serious health problems. Researchers don't yet fully understand what determines how severe the disease will be for different people, and there's limited evidence about which treatments work best. This study will help fill those gaps so that future patients can be diagnosed faster and treated more effectively.
You likely qualify if…
You likely don't qualify if…
As a participant, you would be enrolled in a long-term follow-up study where researchers track your health over time through visits at one of the participating medical centers. You would share your medical history, undergo routine lab tests to measure porphyrin levels, and possibly have genetic testing if not already done. The study aims to enroll about 1,500 patients with various porphyria types across multiple centers.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United States